May 10, 2018 / 11:12 AM / 3 months ago

BRIEF-Keryx Biopharmaceuticals Reports Q1 Loss Per Share Of $0.18

May 10 (Reuters) - Keryx Biopharmaceuticals Inc:

* KERYX BIOPHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.18

* Q1 REVENUE $21.7 MILLION VERSUS I/B/E/S VIEW $21.8 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.18 — THOMSON REUTERS I/B/E/S

* CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018 TOTALED $60.1 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below